Bioprotect raised €21M in a Series D+ round in Sep 2020. The company is based in Tsur Moshe, Israel. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
